triiodothyronine has been researched along with buspirone in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Joffe, RT; Levitt, AJ; Sokolov, ST | 1 |
| Joffe, RT; Sussman, N | 1 |
| Nelson, JC | 2 |
| Cadieux, RJ | 1 |
| Fava, M | 1 |
| Agüera, L; de la Gándara, J; de Pedro, JM; Rojo, JE; Ros, S | 1 |
| Carvalho, AF; Castelo, MS; Cavalcante, JL; Lima, MC | 1 |
| Lieb, K; Tadić, A | 1 |
| Carvalho, AF; Cavalcante, JL; Machado, JR | 1 |
| Berrocoso, E; González-Saiz, F; Mico, JA; Perez-Caballero, L; Romero-López-Alberca, C; Torres-Sanchez, S | 1 |
11 review(s) available for triiodothyronine and buspirone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Augmentation strategies: focus on anxiolytics.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Buspirone; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lithium; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Triiodothyronine | 1996 |
Overcoming treatment resistance in depression.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Lithium; Pindolol; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Triiodothyronine | 1998 |
Practical management of treatment-resistant depression.
Topics: Antidepressive Agents; Buspirone; Depression; Drug Resistance; Drug Therapy, Combination; Humans; Lithium; Pindolol; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Triiodothyronine | 1998 |
New approaches to the treatment of refractory depression.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Pindolol; Piperazines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thyroxine; Triazoles; Triiodothyronine | 2000 |
Augmentation strategies in depression 2000.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Buspirone; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Monoamine Oxidase Inhibitors; Pindolol; Selective Serotonin Reuptake Inhibitors; Triiodothyronine; Tryptophan | 2000 |
Potentiation strategies for treatment-resistant depression.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Lithium; Treatment Outcome; Triiodothyronine | 2005 |
Augmentation strategies for treatment-resistant depression: a literature review.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Buspirone; Central Nervous System Stimulants; Depressive Disorder; Dopamine Agents; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Lithium Compounds; Pindolol; Triiodothyronine | 2007 |
[Pharmacological therapy for therapy-resistant depression. New developments].
Topics: Antidepressive Agents; Brain; Buspirone; Depressive Disorder; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Humans; Lithium Compounds; Randomized Controlled Trials as Topic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Triiodothyronine | 2007 |
Augmentation strategies for treatment-resistant depression.
Topics: Antidepressive Agents; Antipsychotic Agents; Buspirone; Central Nervous System Stimulants; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Humans; Lithium Compounds; Treatment Failure; Triiodothyronine | 2009 |
Monoaminergic system and depression.
Topics: Antidepressive Agents; Antipsychotic Agents; Biogenic Monoamines; Buspirone; Depressive Disorder, Major; Drug Synergism; Excitatory Amino Acid Agents; Humans; Lithium; Pindolol; Triiodothyronine | 2019 |
7 other study(ies) available for triiodothyronine and buspirone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
Antidepressant augmentation: conclusions and recommendations.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Buspirone; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Humans; Lithium; Pindolol; Triiodothyronine | 1998 |